Inspire Medical Systems, Inc. to Report Third Quarter 2022 Financial Results on November 1, 2022
04 Outubro 2022 - 9:00AM
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release
financial results for the third quarter 2022 after the close of
trading on Tuesday, November 1. Inspire’s management team will host
a corresponding conference call beginning at 5:00 p.m. Eastern Time
to discuss the financial results and recent business developments.
To access the call, please use the following
link: Inspire's Q3 2022 earnings call. After registering, an
email will be sent, including dial-in details and a unique
conference call access code required to join the live call. To
ensure you are connected prior to the beginning of the call, the
Company suggests registering a minimum of 10 minutes before the
start of the call.
A simultaneous webcast of the call will be accessible via the
Investor Relations page of the Inspire’s website
at www.inspiresleep.com. For those not planning to ask a
question of management, the Company recommends listening via the
webcast.
Following the call, a replay will be available on the Company's
Investor Relations website approximately two hours after the event
and archived on the site for two weeks.
About Inspire Medical SystemsInspire is a
medical technology company focused on the development and
commercialization of innovative, minimally invasive solutions for
patients with obstructive sleep apnea. Inspire’s proprietary
Inspire therapy is the first and only FDA-approved neurostimulation
technology that provides a safe and effective treatment for
moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit
www.inspiresleep.com.
Investor and Media ContactEzgi YagciVice
President, Investor Relationsezgiyagci@inspiresleep.com
617-549-2443
Inspire Medical Systems (NYSE:INSP)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Inspire Medical Systems (NYSE:INSP)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024